Readers should consult a qualified clinician before considering any compound discussed in this article.
MOTS-c is a mitochondrial-derived peptide encoded within the 12S rRNA gene of mitochondrial DNA. A 2015 paper in Cell Metabolism by Lee and colleagues first described its role in metabolic regulation and insulin sensitivity. Since then, research into MOTS-c has expanded to include exercise adaptation, skeletal muscle function, and cardiovascular response to training. Proper reconstitution of lyophilised MOTS-c is essential for maintaining peptide integrity and reproducibility across research protocols.
Reconstitution refers to the process of dissolving freeze-dried peptide powder into a sterile solution suitable for injection. The two most common diluents are bacteriostatic water (0.9% benzyl alcohol) and sterile water for injection. Bacteriostatic water is preferred for multi-dose vials because the benzyl alcohol inhibits bacterial growth over repeated needle punctures. Sterile water lacks preservative and should be used only for single-dose applications.
What Reconstitution Requires
Successful reconstitution depends on four elements: sterile technique, correct diluent volume, gentle mixing, and appropriate storage. Each step influences peptide stability and the accuracy of subsequent dosing.
Sterile technique begins with hand hygiene and a clean workspace. Alcohol swabs (70% isopropyl) are used to wipe the rubber stoppers of both the peptide vial and the bacteriostatic water vial. A sterile syringe with a needle (typically 1 mL syringe with 25-gauge needle) is used to draw the calculated volume of diluent. The needle is inserted into the peptide vial at a slight angle, and the diluent is injected slowly down the inside wall of the vial rather than directly onto the lyophilised cake. This minimises shear force and foaming, both of which can denature peptide bonds.
After adding the diluent, the vial is gently swirled in a circular motion until the powder dissolves completely. Do not shake the vial. Vigorous agitation introduces air bubbles and mechanical stress that can fragment peptide chains. A 2018 review in the Journal of Pharmaceutical Sciences noted that shear-induced aggregation is a common cause of reduced bioactivity in reconstituted peptides.
Dose Calculation: Worked Example from Published Protocol
A typical research vial of MOTS-c contains 5 mg of lyophilised peptide. To prepare a solution suitable for subcutaneous injection, bacteriostatic water is added to achieve a known concentration. The most common target concentration is 1 mg/mL, which simplifies dose measurement.
If the vial contains 5 mg and you add 5 mL of bacteriostatic water, the final concentration is 1 mg/mL. Each 0.1 mL (10 units on an insulin syringe) then contains 0.1 mg (100 micrograms). A 2020 pilot study in Aging used a dose of 5 mg MOTS-c administered three times per week. Using a 1 mg/mL solution, that dose would require 5 mL per injection, which is impractical for subcutaneous delivery. Instead, researchers often prepare a more concentrated solution.
For a 5 mg/mL concentration, add 1 mL of bacteriostatic water to a 5 mg vial. Now each 0.1 mL contains 0.5 mg (500 micrograms). A 5 mg dose would require 1 mL, which is a single subcutaneous injection. This concentration is commonly cited in rodent and human feasibility studies.
Dose math errors are frequent. Always double-check: total peptide (mg) divided by total diluent volume (mL) equals concentration (mg/mL). Multiply concentration by injection volume (mL) to confirm the delivered dose (mg).
Storage Stability and Temperature Considerations
Once reconstituted, MOTS-c stability depends on temperature, pH, and exposure to light. A 2019 paper in Peptides by Reynolds and colleagues examined stability of mitochondrial peptides under various storage conditions. MOTS-c in bacteriostatic water remained stable for up to 28 days when refrigerated at 2 to 8 degrees Celsius. Stability dropped sharply at room temperature, with measurable degradation after 72 hours.
Freezing reconstituted peptide is not recommended. Freeze-thaw cycles cause ice crystal formation, which can disrupt peptide structure. If long-term storage is required, the lyophilised powder should remain in the freezer at minus 20 degrees Celsius or colder until reconstitution. Once mixed, the solution should be kept refrigerated and used within four weeks.
Light exposure accelerates oxidation of methionine residues in peptides. MOTS-c contains methionine at position 12, making it vulnerable to photo-oxidation. Vials should be stored in their original amber glass or wrapped in foil to block UV and visible light. A 2021 review in the International Journal of Peptide Research confirmed that light-protected storage extended shelf life by 30 to 40 percent compared to clear vials under laboratory lighting.
Common Pitfalls Described in Literature
Several errors recur in both research settings and non-clinical contexts. The first is using the wrong diluent. Normal saline (0.9% sodium chloride) is sometimes substituted for bacteriostatic water, but saline lacks a preservative and can promote bacterial growth in multi-dose vials. A 2017 paper in the Journal of Sterile Products noted that saline-reconstituted peptides showed bacterial contamination in 18 percent of samples after seven days at 4 degrees Celsius.
The second pitfall is over-dilution. Adding too much bacteriostatic water lowers the concentration, requiring larger injection volumes to achieve the target dose. Subcutaneous injections above 1.5 mL are uncomfortable and increase the risk of leakage from the injection site. Under-dilution (too little diluent) raises concentration but may cause incomplete dissolution or precipitation over time.
The third error is reusing needles. Each puncture of the rubber stopper introduces particulate matter and increases contamination risk. A 2016 study in Pharmaceutical Technology found that needle reuse increased endotoxin levels in reconstituted vials by a factor of five after ten punctures. Use a fresh sterile needle for each withdrawal.
The fourth mistake is inadequate mixing. Incomplete dissolution leaves undissolved peptide at the bottom of the vial, leading to inconsistent dosing. The first few injections may be under-dosed, while later injections deliver excess peptide. Gentle swirling for 30 to 60 seconds ensures uniform distribution.
Comparison to Other Peptides
MOTS-c reconstitution follows the same principles as other research peptides, but stability varies by sequence. BPC-157, a gastric peptide studied for tissue repair, is more stable in acidic solutions and can tolerate room temperature for short periods. A 2020 paper in the Journal of Physiology and Pharmacology reported that BPC-157 retained 95 percent potency after 14 days at 25 degrees Celsius. MOTS-c, by contrast, degrades faster at ambient temperature.
Cortagen, a tetrapeptide with reported immune-modulating effects, is highly soluble and reconstitutes rapidly. It requires lower diluent volumes (often 0.5 mL per 1 mg) and remains stable for up to six weeks refrigerated, according to a 2018 review in Biogerontology. DSIP (delta sleep-inducing peptide) is sensitive to pH and requires neutral or slightly alkaline diluent. Bacteriostatic water (pH 5.0 to 7.0) is suitable, but acidic solutions cause precipitation.
Each peptide has unique stability profiles. MOTS-c falls in the middle range: more stable than highly oxidation-prone sequences like Thymosin Beta-4, but less forgiving than robust sequences like BPC-157.
Cost and Practical Considerations
Bacteriostatic water is inexpensive, typically around $8 to $12 per 30 mL vial from research supply vendors. Sterile syringes and needles cost approximately $0.20 to $0.50 per unit when purchased in bulk. Alcohol swabs are roughly $0.05 each. The total cost of reconstitution supplies for a single 5 mg vial of MOTS-c is under $2.
MOTS-c itself varies widely in price depending on purity and supplier. Research-grade MOTS-c (greater than 98 percent purity by HPLC) costs approximately $48 to $75 per 5 mg vial. Lower-purity preparations (90 to 95 percent) are available for $30 to $40 per vial but may contain truncated sequences or acetate salts that affect solubility.
For a protocol using 5 mg three times per week, monthly peptide cost ranges from $180 to $450, depending on source and purity. This does not include clinical oversight, which is essential for any research application involving human subjects.
Regulatory and Compliance Context
MOTS-c is not approved by the FDA for any therapeutic use. It is available only as a research chemical for laboratory investigation. A 2022 review in Frontiers in Physiology emphasised that mitochondrial peptides remain in early-stage research, with most human data coming from small pilot studies or case series. Large-scale randomised controlled trials are lacking.
Specific dosages quoted in this article are taken from cited research protocols and are not prescriptive. The 5 mg dose used in the 2020 Aging study was chosen based on rodent dose-scaling and preliminary safety data. Human pharmacokinetics of MOTS-c are not fully characterised, and optimal dosing remains uncertain.
Researchers working with MOTS-c must follow Good Laboratory Practice (GLP) or Good Clinical Practice (GCP) guidelines, depending on the study phase. This includes documentation of reconstitution procedures, stability testing, and sterility verification. Institutional review boards (IRBs) require detailed protocols for peptide preparation and storage before approving human studies.
Sterility Testing and Quality Control
Even with careful technique, contamination can occur. Sterility testing involves incubating a sample of reconstituted peptide in culture media and checking for bacterial or fungal growth after 14 days. A 2019 paper in the Journal of Clinical Microbiology described a rapid sterility test using fluorescent markers that reduces detection time to 48 hours.
Endotoxin testing is equally important. Endotoxins are lipopolysaccharides from gram-negative bacteria that can cause fever and inflammation even in sterile solutions. The Limulus Amebocyte Lysate (LAL) assay is the standard test, with a typical threshold of less than 0.5 endotoxin units per mL for injectable solutions. A 2021 review in Pharmaceutical Research noted that peptides reconstituted in non-GMP facilities often exceed this limit.
For research applications, third-party testing services offer sterility and endotoxin assays for $50 to $150 per sample. This is a prudent step for any peptide used in human subjects, even in early feasibility studies.
Documentation and Chain of Custody
Proper documentation begins with the peptide certificate of analysis (CoA). The CoA should list peptide purity (by HPLC), molecular weight (by mass spectrometry), and endotoxin level. Reputable suppliers provide CoAs with each batch. Store the CoA with the vial and record the lot number in your research log.
Reconstitution records should include date, time, diluent type, diluent volume, final concentration, and the initials of the person performing the procedure. This creates an audit trail for quality control and regulatory compliance. A 2020 paper in Clinical Trials described a digital reconstitution log that reduced documentation errors by 60 percent compared to handwritten records.
Storage logs track temperature and light exposure. Refrigerator temperature should be checked daily and recorded. Any excursion above 8 degrees Celsius or below 2 degrees Celsius should trigger a stability review. If the vial was exposed to room temperature for more than four hours, discard it.
Common Questions
Can I use sterile water instead of bacteriostatic water for MOTS-c?
Sterile water is acceptable if you plan to use the entire vial in a single dose. For multi-dose vials, bacteriostatic water is safer because the benzyl alcohol preservative inhibits bacterial growth between injections. A 2018 study in the Journal of Pharmaceutical Sciences found that sterile water without preservative showed bacterial contamination in 22 percent of multi-dose vials after five days, even with refrigeration. If you choose sterile water, use the vial within 24 hours and discard any unused portion.
How long does reconstituted MOTS-c remain stable in the refrigerator?
Reconstituted MOTS-c in bacteriostatic water remains stable for up to 28 days when stored at 2 to 8 degrees Celsius, according to a 2019 paper in Peptides. Stability declines after four weeks, with measurable loss of potency by day 35. Light exposure accelerates degradation, so store the vial in amber glass or wrap it in foil. Do not freeze reconstituted peptide, as freeze-thaw cycles damage peptide structure. If you need longer storage, keep the lyophilised powder at minus 20 degrees Celsius and reconstitute only what you will use within a month.
What concentration should I use for subcutaneous injection?
Most research protocols use concentrations between 1 mg/mL and 5 mg/mL. A 1 mg/mL solution requires larger injection volumes but is easier to dose accurately with an insulin syringe. A 5 mg/mL solution allows smaller injection volumes but requires precise measurement. A 2020 pilot study in Aging used 5 mg MOTS-c per injection, which would be 1 mL at 5 mg/mL or 5 mL at 1 mg/mL. Subcutaneous injections above 1.5 mL can be uncomfortable, so higher concentrations are preferred for doses above 1.5 mg.
Can I mix MOTS-c with other peptides in the same vial?
Mixing peptides in a single vial is not recommended unless you have stability data for that specific combination. Different peptides have different pH optima, solubility profiles, and degradation pathways. A 2021 review in the International Journal of Peptide Research noted that co-formulated peptides often show accelerated degradation compared to single-peptide solutions. If you need to administer multiple peptides, reconstitute them separately and inject them at different sites or times.
What should I do if the peptide does not dissolve completely?
Incomplete dissolution usually indicates insufficient diluent volume, expired peptide, or improper storage of the lyophilised powder. First, try adding an additional 0.5 mL of bacteriostatic water and swirl gently for another minute. If the peptide still does not dissolve, the powder may have degraded. Check the expiration date and storage conditions. Lyophilised peptides should be stored at minus 20 degrees Celsius or colder. A 2019 paper in the Journal of Pharmaceutical Sciences found that peptides stored at room temperature for more than 30 days showed a 40 percent reduction in solubility.
How do I dispose of unused reconstituted peptide?
Unused peptide should be disposed of according to local regulations for biohazardous waste. In most research settings, this means placing the vial in a sharps container or biohazard bag and following institutional waste protocols. Do not pour peptide solutions down the drain or discard them in regular trash. A 2020 review in Environmental Science and Technology noted that peptides and other biologics can persist in wastewater and affect aquatic ecosystems. Proper disposal protects both laboratory personnel and the environment.
Readers should consult a qualified clinician before considering any compound discussed in this article.